title: [Mutation and clinical relevance in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy].
abstract: OBJECTIVE
  To explore the genetic basis and phenotypic correlation with disease severity in a large cohort of Chinese patients with hypertrophic cardiomyopathy (HCM).
  
  
  METHODS
  A total of 179 unrelated Chinese HCM patients admitted to our department from 2002 to 2011 were enrolled in this study. Direct gene sequencing of β-myosin heavy chain (MYH7), myosin binding protein-C ( MYBPC3), and cardiac troponin T (TNNT2) were performed and clinical data were obtained in these patients.
  
  
  RESULTS
  A total of 34 mutations were identified in 40 patients (22.3%), 79.4% (27/34) mutations occurred only once and a possible hot spot, A26 in MYH7, was found. Distribution of mutations was 52.9% (18/34) (MYBPC3), 35.3% (12/34) ( MYH7) and 11.8% (4/34) (TNNT2) respectively. Double mutations were identified in 2.2% (4/179) patients. Genotype-positive patients were associated with an earlier symptom onset, severer left ventricular hypertrophy, a higher incidence of syncope, and were more likely to have positive family history of HCM or sudden cardiac death (SCD) , and were more likely to progress into heart failure (24.2% vs. 5.0%, P = 0.002) and at a higher risk of SCD (9.1% vs. 0, P = 0.009) during the 6.5-year follow-up. No statistical difference in any clinical parameters and outcomes was found between patients carrying MYBPC3 and MYH7 mutations. Double mutations were associated with malignant clinical progression in this cohort. Different phenotype severity could be seen in HCM patients with same genotype (e. g. MYH7-1736T, TNNT2-R92W).
  
  
  CONCLUSIONS
  MYBPC3 is the most predominant gene mutation in this HCM cohort. The presence of a sarcomere mutation in patients with HCM is associated with poor clinical outcome, although no specific genes or mutations can exactly predict the severity of clinical phenotypes.
authors.forename: Liu
authors.initials: L
authors.lastname: Jie
authors.forename: Liu
authors.initials: L
authors.lastname: Wenling
authors.forename: Hu
authors.initials: H
authors.lastname: Dayi
authors.forename: Zhu
authors.initials: Z
authors.lastname: Tiangang
authors.forename: Liu
authors.initials: L
authors.lastname: Wen
authors.forename: Ma
authors.initials: M
authors.lastname: Zhanfeng
authors.forename: Yang
authors.initials: Y
authors.lastname: Jie
authors.forename: Xie
authors.initials: X
authors.lastname: Wenli
authors.forename: Li
authors.initials: L
authors.lastname: Cuilan
authors.forename: Li
authors.initials: L
authors.lastname: Lei
authors.forename: Pan
authors.initials: P
authors.lastname: Guozhong
mesh_terms: D044466:Asian People; D002312:Cardiomyopathy, Hypertrophic; D002352:Carrier Proteins; D016757:Death, Sudden, Cardiac; D018450:Disease Progression; D005838:Genotype; D006801:Humans; D017379:Hypertrophy, Left Ventricular; D009154:Mutation; D010641:Phenotype; D012518:Sarcomeres; D020107:Troponin T; D024723:Ventricular Myosins; D000099163:Myosin Binding Protein C
chemical_list: D002352:Carrier Proteins; D020107:Troponin T; D024723:Ventricular Myosins; D000099163:Myosin Binding Protein C